| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Metabolic Medicine (M.A.C., C.W.L.R., R.L.B., A.P., M.P., M.A.G., S.R.B.) and Dietetics (S.M.E., G.S.F.), Imperial College London, Hammersmith Hospital Campus, London, United Kingdom W12 0NN
Address all correspondence and requests for reprints to: Prof. Stephen R. Bloom, Department of Metabolic Medicine, Imperial College London at Hammersmith Campus, Du Cane Road, London, United Kingdom W12 0NN. E-mail: s.bloom{at}imperial.ac.uk.
Oxyntomodulin (OXM) is released from the gut postprandially, in proportion to energy intake, and circulating levels of OXM are elevated in several conditions associated with anorexia. Central injection of OXM reduces food intake and weight gain in rodents, suggesting that OXM signals food ingestion to hypothalamic appetite-regulating circuits. We investigated the effect of iv OXM (3.0 pmol/kg·min) on appetite and food intake in 13 healthy subjects (body mass index, 22.5 ± 0.9 kg/m2) in a randomized, double-blind, placebo-controlled, cross-over study. Infusion of OXM significantly reduced ad libitum energy intake at a buffet meal (mean decrease, 19.3 ± 5.6%; P < 0.01) and caused a significant reduction in scores for hunger. In addition, cumulative 12-h energy intake was significantly reduced by infusion of OXM (mean decrease, 11.3 ± 6.2%; P < 0.05). OXM did not cause nausea or affect food palatability. Preprandial levels of the appetite-stimulatory hormone, ghrelin, were significantly suppressed by OXM (mean reduction, 44 ± 10% of postprandial decrease; P < 0.0001). Elevated levels of endogenous OXM associated with disorders of the gastrointestinal tract may contribute to anorexia.
This work was supported by grants from the Medical Research Council, United Kingdom (to M.A.C.), and the Wellcome Trust (to C.L.R., R.L.B., and A.P.).
Abbreviations: GLP-1, Glucagon-like peptide-1; GLP-1R, glucagon-like peptide-1 receptor; OLI, oxyntomodulin-like immunoreactivity; OXM, oxyntomodulin; PYY, peptide YY; VAS, visual analog scales.
This article has been cited by other articles:
![]() |
V. E F Crowley Overview of human obesity and central mechanisms regulating energy homeostasis Ann Clin Biochem, May 1, 2008; 45(3): 245 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Bloom, F. P. Kuhajda, I. Laher, X. Pi-Sunyer, G. V. Ronnett, T. M.M. Tan, and D. S. Weigle The Obesity Epidemic: Pharmacological Challenges Mol. Interv., April 1, 2008; 8(2): 82 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. B. Chaudhri, K. Wynne, and S. R. Bloom Can Gut Hormones Control Appetite and Prevent Obesity? Diabetes Care, February 1, 2008; 31(Supplement_2): S284 - S289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Latshaw Daily Energy Intake of Broiler Chickens is Altered by Proximate Nutrient Content and Form of the Diet Poult. Sci., January 1, 2008; 87(1): 89 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Parlevliet, A. C. Heijboer, J. P. Schroder-van der Elst, L. M. Havekes, J. A. Romijn, H. Pijl, and E. P. M. Corssmit Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E142 - E147. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. M. Smeets, S. Vidarsdottir, C. de Graaf, A. Stafleu, M. J. P. van Osch, M. A. Viergever, H. Pijl, and J. van der Grond Oral glucose intake inhibits hypothalamic neuronal activity more effectively than glucose infusion Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E754 - E758. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jorgensen, V. Kubale, M. Vrecl, T. W. Schwartz, and C. E. Elling Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor beta-Arrestin Recruitment and Signaling through G{alpha} J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 148 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Sowden, D. J. Drucker, D. Weinshenker, and S. J. Swoap Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R962 - R970. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Murphy, W. S. Dhillo, and S. R. Bloom Gut Peptides in the Regulation of Food Intake and Energy Homeostasis Endocr. Rev., December 1, 2006; 27(7): 719 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Foster-Schubert and D. E. Cummings Emerging Therapeutic Strategies for Obesity Endocr. Rev., December 1, 2006; 27(7): 779 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Gosman, H. I. Katcher, and R. S. Legro Obesity and the role of gut and adipose hormones in female reproduction Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Druce and S R Bloom The regulation of appetite Arch. Dis. Child., February 1, 2006; 91(2): 183 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Neary, C. J. Small, M. R. Druce, A. J. Park, S. M. Ellis, N. M. Semjonous, C. L. Dakin, K. Filipsson, F. Wang, A. S. Kent, et al. Peptide YY3-36 and Glucagon-Like Peptide-17-36 Inhibit Food Intake Additively Endocrinology, December 1, 2005; 146(12): 5120 - 5127. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M Sinclair and D. J. Drucker Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential Physiology, October 1, 2005; 20(5): 357 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wynne, A. J. Park, C. J. Small, M. Patterson, S. M. Ellis, K. G. Murphy, A. M. Wren, G. S. Frost, K. Meeran, M. A. Ghatei, et al. Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects: A Double-Blind, Randomized, Controlled Trial Diabetes, August 1, 2005; 54(8): 2390 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Badman and J. S. Flier The Gut and Energy Balance: Visceral Allies in the Obesity Wars Science, March 25, 2005; 307(5717): 1909 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wynne, S. Stanley, B. McGowan, and S. Bloom Appetite control J. Endocrinol., February 1, 2005; 184(2): 291 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. le Roux and S. R. Bloom Why Do Patients Lose Weight after Roux-en-Y Gastric Bypass? J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 591 - 592. [Full Text] [PDF] |
||||
![]() |
K.G. Murphy and S.R. Bloom Gut hormones in the control of appetite Exp Physiol, September 1, 2004; 89(5): 507 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Holst and J. Gromada Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E199 - E206. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wynne, S. Stanley, and S. Bloom The Gut and Regulation of Body Weight J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2576 - 2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Korner and L. J. Aronne Pharmacological Approaches to Weight Reduction: Therapeutic Targets J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2616 - 2621. [Full Text] [PDF] |
||||
![]() |
C. L. Dakin, C. J. Small, R. L. Batterham, N. M. Neary, M. A. Cohen, M. Patterson, M. A. Ghatei, and S. R. Bloom Peripheral Oxyntomodulin Reduces Food Intake and Body Weight Gain in Rats Endocrinology, June 1, 2004; 145(6): 2687 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Druce, C. J. Small, and S. R. Bloom Minireview: Gut Peptides Regulating Satiety Endocrinology, June 1, 2004; 145(6): 2660 - 2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Broglio, C. Gottero, P. Van Koetsveld, F. Prodam, S. Destefanis, A. Benso, C. Gauna, L. Hofland, E. Arvat, A. J. van der Lely, et al. Acetylcholine Regulates Ghrelin Secretion in Humans J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2429 - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stanley, K. Wynne, and S. Bloom Gastrointestinal Satiety Signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G693 - G697. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |